Dr. Jonathan J. Shuster
Clear Passage affiliation:
- Study Design
- Biostatistical Analysis
- Data Reporting
Academic history and affiliations:
- Research Professor, Health Outcomes and Policy, College of Medicine (1969)
- Research Professor, Health Outcomes and Policy, College of Medicine (2004)
- Faculty, Institute on Child Health Policy, College of Medicine (2008)
- Professor, Statistics, Statistics, College of Liberal Arts and Sciences (1980 – 2002)
- Associate Chair of Statistics, College of Medicine, University of Florida Health Science Center (2000 – 2001)
- Associate Professor, Statistics, College of Liberal Arts and Sciences (1974 – 1980)
- Visiting Associate Professor, math and statistics, McGill University (1976 – 1977)
- Assistant Professor, Statistics, College of Liberal Arts and Sciences (1969 – 1974)
- Lecturer, Math, McGill University (1968 – 1969)
- Lecturer, Math and Statistics, Sir George Williams University (1966 – 1968)
- Professor of Statistics, University of Florida
Dr. Shuster is an expert in statistical methodology for the design and analysis of clinical trials. Published results of his research appear in The New England Journal of Medicine, Journal of Clinical Oncology, Leukemia, Statistics in Medicine and other major medical and statistics/biostatistics journals. His book, Practical Handbook of Sample Sizes for Clinical Trials, is widely used in medical research. Shuster was named a fellow of the American Statistical Association for his work on successful treatments of childhood cancers and his scholarship in clinical trial statistical methodology.
As director of the COG Research Data Center, Shuster is responsible for the data from all COG clinical trials and biological studies of cancer patients from more 250 hospitals and medical centers in the United States, Canada, Switzerland, the Netherlands and Australia. In the United States, more than 90% of children diagnosed with cancer prior to age 15 receive treatment from COG institutions.
His efforts in cancer research have led to spectacular results – including a high cure rate with some types of leukemia. In 1996, he discovered a significant pharmacological interaction between two common anti-cancer medications. This finding had a major impact on leukemia and lymphoma treatment for both children and adults.